Anethole trithione, anetholtrithione, or anetholtrithion (JAN) is a drug used in the treatment of dry mouth. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer.[1] Anethole trithione is an organosulfur compound, specifically, a dithiole-thione derivative.[2]
 | |
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.754 |
| Chemical and physical data | |
| Formula | C10H8OS3 |
| Molar mass | 240.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Brand names
edit- Felviten
- Halpen
- Hepasulfol - Franco-Indian Pharmaceuticals
- Heporal
- Mucinol - Sanofi-Aventis
- Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma
- Sonicur - Solvay
- Sulfarlem - Solvay; Aguettant; Edward Keller; Sanofi-Aventis
- Sulfarlem S - EG Labo
- Tiopropen
- Tiotrifar
See also
editReferences
edit- ^ Anetholtrithione entry in the public domain NCI Dictionary of Cancer Terms. Retrieved September 13, 2008.
- ^ Christen MO (1995). "Anethole dithiolethione: Biochemical considerations". Biothiols Part B: Glutathione and Thioredoxin: Thiols in Signal Transduction and Gene Regulation. Methods in Enzymology. Vol. 252. pp. 316–23. doi:10.1016/0076-6879(95)52034-1. ISBN 9780121821531. PMID 7476368.
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |